Skip to main content
. 2022 Mar 30;19(1):452–467. doi: 10.1080/15476286.2022.2052641

Figure 1.

Figure 1.

Delivery platforms in siRNAs drugs in advance clinical trials. A. lipid nanoparticle (LNP) encapsulated siRNA B. GalNAc conjugation C. GalXC RNAi technology.